James Bolognese, MStat
Senior Research Advisor, Cytel Inc.
Jim Bolognese is a highly experienced biostatistician with a career spanning over four decades. Since 2009 at Cytel, Jim has served as a biostatistical consultant to biotech companies on clinical trial design and drug development strategy, including rare diseases and adaptive designs, and collaborates on software development for clinical trial design optimization via simulation. He was awarded American Statistical Association Fellow in 2017 and has coauthored over 100 papers. Before joining Cytel, he spent 33 years at Merck Research Labs, where he served as a biostatistician in all phases of drug development across multiple therapeutic areas, from pre-clinical through outcomes trials, including biomarker development. Jim has a BS in Mathematics from Bucknell University and a Master of Statistics from the University of Florida.
